Ireland vs Maldives: The number of people with susceptibility test result for rifampicin
Ireland
40
in 2021
Maldives
46
in 2021
Ireland rank
125th
Maldives rank
123rd
The number of people with susceptibility test result for rifampicin over time
- Ireland
- Maldives
How they compare
Maldives currently reports 46 against 40 in Ireland, a difference of 6.
That makes Maldives's figure about 1.1 times Ireland's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Ireland ahead.
Ireland ranks 125th and Maldives ranks 123rd of 155 countries.
Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ireland | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95 | 76 | 19 | Ireland |
| 2020s | 53 | 44.5 | 8.5 | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Ireland or Maldives?
- Maldives, at 46 against 40 in Ireland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Ireland and Maldives?
- 6, with Maldives ahead.
- How many years of comparable data are there for Ireland and Maldives?
- 5 years are reported by both, from 2017 to 2021.
- How do Ireland and Maldives rank globally for the number of people with susceptibility test result for rifampicin?
- Ireland ranks 125th and Maldives ranks 123rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.